Shop Research About Compliance Affiliate Free Consultation
POPULAR

CJC-1295 (With DAC)

GHRH Analog · Drug Affinity Complex

Long-acting GHRH analog with Drug Affinity Complex (DAC). Extended albumin-binding half-life model for GH pulse research.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Ships in 24hr ✓ US-Based ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
CJC-1295 (With DAC) research peptide vial
Select Size
✓ Added to cart View Cart →
Research Data

What Is CJC-1295 (With DAC)?

CJC-1295 with DAC is a synthetic analogue of growth hormone releasing hormone (GHRH 1-29) modified with a Drug Affinity Complex (DAC) that enables covalent binding to serum albumin, dramatically extending its half-life to approximately 6–8 days. Research uses this compound for sustained GH pulse models and pituitary axis studies requiring infrequent dosing intervals.

Research Context

  • Extended-half-life GHRH analog via albumin DAC conjugation (~6–8 day t½)
  • Pituitary GH secretion axis studies with sustained stimulation
  • IGF-1 pathway modeling with prolonged GHRH signaling
  • Comparison with short-acting CJC-1295 (No DAC) in pulse studies

Storage & Reconstitution

Store lyophilized at −20°C. Reconstituted: 2–8°C, use within 4 weeks.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.